{"id":"W2120793461","doi":"10.1016/s0140-6736(04)17101-8","title":"Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial","year":2004,"lang":"en","type":"article","venue":"The Lancet","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":false,"ca_institutions":"St. Michael's Hospital","funders":"Fondation Charcot; Bayer Fund; Bayer Corporation","keywords":"Medicine; Placebo; Expanded Disability Status Scale; Multiple sclerosis; Pulmonary embolism; Internal medicine; Hazard ratio; Clinical trial; Randomized controlled trial; Surgery; Confidence interval; Immunology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003210726,0.003299976,0.01030602,0.00112775,0.0009002931,0.001956875,0.00179276,0.005874089,0.0111064],"category_scores_gemma":[0.004118884,0.001166484,0.004701618,0.001295924,0.002874815,0.001620927,0.0008562012,0.004906974,0.001775803],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00164936,"about_ca_system_score_gemma":0.001495494,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003142386,"about_ca_topic_score_gemma":0.003717861,"domain_scores_codex":[0.9977515,0.001204886,0.0001833655,0.0003315505,0.0001615806,0.0003670706],"domain_scores_gemma":[0.9979008,0.0009309244,0.0004091178,0.0001691804,0.0001599655,0.0004299066],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9912236,0.0007987181,0.0001133246,0.001607773,0.00132165,0.00003091193,0.0000214437,0.00006560202,0.0004824373,0.00007314575,0.0003524681,0.003908983],"study_design_scores_gemma":[0.9904771,0.008182973,0.0002644215,0.0000704795,0.0005949451,0.000009829878,0.00000988985,0.00004413377,0.00005516436,0.00007714982,0.000207549,0.000006368783],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8650219,0.09801514,0.002577637,0.004367927,0.008834896,0.0101993,0.002989624,0.0004120331,0.007581505],"genre_scores_gemma":[0.9481014,0.0258215,0.002014793,0.00337203,0.003381281,0.007147698,0.001231702,0.00004513311,0.008884479],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0111064,"threshold_uncertainty_score":0.03715461,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05653824628512365,"score_gpt":0.3067764742144048,"score_spread":0.2502382279292811,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}